Natixis Advisors LLC Increases Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Natixis Advisors LLC raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 195,291 shares of the company’s stock after buying an additional 1,302 shares during the quarter. Natixis Advisors LLC owned about 0.21% of Acadia Healthcare worth $7,743,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Atria Investments Inc raised its position in shares of Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after purchasing an additional 308 shares during the last quarter. KBC Group NV raised its position in shares of Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after purchasing an additional 338 shares during the last quarter. Landscape Capital Management L.L.C. purchased a new position in Acadia Healthcare in the 3rd quarter worth about $1,028,000. Charles Schwab Investment Management Inc. raised its position in Acadia Healthcare by 2.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,127,061 shares of the company’s stock worth $71,467,000 after buying an additional 29,936 shares during the last quarter. Finally, Cerity Partners LLC raised its position in Acadia Healthcare by 43.7% in the 3rd quarter. Cerity Partners LLC now owns 32,922 shares of the company’s stock worth $2,088,000 after buying an additional 10,019 shares during the last quarter.

Analysts Set New Price Targets

ACHC has been the subject of a number of recent analyst reports. Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Bank of America cut their price target on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research note on Friday, February 28th. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $43.00 to $35.00 in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Finally, TD Cowen cut their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare has an average rating of “Hold” and a consensus price target of $56.31.

Acadia Healthcare Trading Down 0.9 %

Shares of NASDAQ:ACHC opened at $29.01 on Friday. The stock has a 50 day moving average of $38.88 and a 200 day moving average of $47.32. The company has a market cap of $2.70 billion, a PE ratio of 9.51, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 12-month low of $27.61 and a 12-month high of $82.41.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.